Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NanoString Technologies Appoints Senior Financial Executive

Published: Wednesday, July 18, 2012
Last Updated: Wednesday, July 18, 2012
Bookmark and Share
Greg Norden welcomed to Board of Directors. Mr. Norden will serve as the Chairman of NanoString's Audit Committee.

Mr. Norden is a senior executive with more than 25 years of leadership in financial management and strategy, including a 21-year career at Wyeth, where he was most recently Senior Vice President and Chief Financial Officer. Wyeth was acquired by Pfizer in October 2009 in a transaction valued at $68 billion. Prior to his corporate CFO role, Mr. Norden was Executive Vice President and Chief Financial Officer, Wyeth Pharmaceuticals and held a number of other positions of increasing responsibility from initially joining Wyeth/American Home Products in 1989. Earlier in his career, Mr. Norden worked at Arthur Andersen & Co.

"With a rapidly growing life sciences business and a capability for developing high-value molecular diagnostics, NanoString Technologies is poised to transform both the study and treatment of disease," said Mr. Norden. "I am excited to join NanoString's Board of Directors, and to help the company scale these businesses."

Mr. Norden received his B.S. from the State University of New York - Plattsburgh and received his M.S. from Long Island University - C. W. Post. He also serves on the Board of Directors of Human Genome Sciences /quotes/zigman/55662/quotes/nls/hgsi HGSI +0.04% , a public biopharmaceutical company, and WelchAllyn, a leading global provider of medical diagnostic equipment.

"Greg brings more than two decades of healthcare industry experience and an impeccable track record of leading financial and administrative operations," said William D. Young, Executive Chairman of the Board for NanoString Technologies. "We look forward to benefiting from his experience as CFO of a global Fortune 120 corporation as we prepare for the next stage of NanoString's growth."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NanoString Technologies Receives FDA 510(k) Clearance for Prosigna™ Breast Cancer Prognostic Gene Signature Assay
Prosigna assay on the nCounter® Dx analysis system provides compelling clinical data, clear patient report, and decentralized testing in qualified labs.
Tuesday, September 17, 2013
Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!